[go: up one dir, main page]

ES8801118A1 - Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado. - Google Patents

Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.

Info

Publication number
ES8801118A1
ES8801118A1 ES556651A ES556651A ES8801118A1 ES 8801118 A1 ES8801118 A1 ES 8801118A1 ES 556651 A ES556651 A ES 556651A ES 556651 A ES556651 A ES 556651A ES 8801118 A1 ES8801118 A1 ES 8801118A1
Authority
ES
Spain
Prior art keywords
moisturizing agent
forming
mixture
liposome
phospholypen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556651A
Other languages
English (en)
Other versions
ES556651A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25067952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8801118(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of ES8801118A1 publication Critical patent/ES8801118A1/es
Publication of ES556651A0 publication Critical patent/ES556651A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR COMPOSICIONES FORMADORAS DE LIPOSOMAS. COMPRENDE: A) FORMAR UNA MEZCLA DE MATERIAL FOSFOLIPIDICO FORMADOR DE LIPOSOMAS ENTRE 20 Y 45JC; B) AÑADIR UN AGENTE HIDRATANTE EN LA MEZCLA Y EN UNA RELACION MOLAR ENTRE 1:20 Y 1:0,05 DE DICHO AGENTE HIDRATANTE RESPECTO AL MATERIAL FORMADOR DE LIPOSOMAS; C) AGREGAR A LA MEZCLA DE B) UN FARMACO QUE HA DE SER ENCAPSULADO; Y D) DISPERSAR LA MEZCLA DE C) EN UNA SOLUCION ACUOSA. EL AGENTE HIDRATANTE SE ELIGE ENTRE ARGININA, ASPARAFINA, LISINA Y OTROS Y EL MATERIAL FOSFOLIPIDICO FORMADOR DE LIPOSOMAS SE ELIGEN ENTRE GLICOLIPIDOS, ESFINGOLIPIDOS Y ACILGLICEROLES. SE UTILIZAN EN LA INDUSTRIA AGRICOLA, FARMACEUTICA O COSMETICA.
ES556651A 1985-08-07 1986-06-25 Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado. Expired ES8801118A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76348485A 1985-08-07 1985-08-07

Publications (2)

Publication Number Publication Date
ES8801118A1 true ES8801118A1 (es) 1987-12-16
ES556651A0 ES556651A0 (es) 1987-12-16

Family

ID=25067952

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556651A Expired ES8801118A1 (es) 1985-08-07 1986-06-25 Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.

Country Status (20)

Country Link
EP (1) EP0211647B1 (es)
JP (1) JP2511417B2 (es)
KR (1) KR900007185B1 (es)
CN (1) CN1027491C (es)
AT (1) ATE94754T1 (es)
AU (1) AU601154B2 (es)
CA (1) CA1280975C (es)
DE (1) DE3689056T2 (es)
DK (1) DK362786A (es)
ES (1) ES8801118A1 (es)
FI (1) FI863227A7 (es)
GR (1) GR862020B (es)
HK (1) HK1004530A1 (es)
HU (1) HU198836B (es)
IE (1) IE61445B1 (es)
IL (1) IL79114A (es)
NO (1) NO863176L (es)
NZ (1) NZ216768A (es)
PT (1) PT83130B (es)
ZA (1) ZA864541B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
IT1214540B (it) * 1986-10-23 1990-01-18 Vincenzo Zappia Mario De Rosa Formulazioni idrosolubili di ubidecarenoni, procedimento per laloro preparazione e composizioni farmaceutiche che li compongono.
EP0287646B1 (en) * 1986-10-23 1992-05-20 Arval S.P.A. Cosmetic preparations containing ubidecarenones
CA1336761C (en) * 1987-10-19 1995-08-22 Christine E. Swenson Aqueous preparation of liposomal composition
FR2631234B1 (fr) * 1988-05-10 1990-09-14 Dior Christian Parfums Composition cosmetique ou dermatologique, notamment a action amincissante ou anti-cellulitique contenant des extraits de cola sous forme libre ou sous forme liposomale
JP2786482B2 (ja) * 1988-06-29 1998-08-13 第一製薬株式会社 脂質膜構造体
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
JP3218637B2 (ja) * 1990-07-26 2001-10-15 大正製薬株式会社 安定なリポソーム水懸濁液
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
WO1992003122A1 (de) * 1990-08-24 1992-03-05 Gregor Cevc Präparat zur wirkstoffapplikation in kleinsttröpfchenform
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
CA2087691A1 (en) * 1992-01-23 1993-07-24 Peter Critchley Cosmetic compositon
GB9224502D0 (en) * 1992-11-23 1993-01-13 New Roger R C Method of preparing a lipid-containing formulation
CA2156525A1 (en) * 1993-02-19 1994-09-01 Susan Dillon Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
DE69328545T2 (de) * 1993-03-24 2001-07-05 Collaborative Laboratories Inc., East Setauket Kosmetisches Verabreichungssystem für Salizylsäure und Verfahren zur Herstellung desselben
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
JPH0757826A (ja) * 1993-08-18 1995-03-03 Nec Corp 端子台
TW520294B (en) * 1998-01-08 2003-02-11 Res Dev Foundation Stabilization of lipid: DNA formulations during nebulization
US6375980B1 (en) * 1998-01-08 2002-04-23 Research Development Foundation Stabilization of lipid:DNA formulations during nebulization
CZ20012038A3 (cs) 1998-12-23 2001-09-12 Idea Ag Zdokonalený přípravek pro topické, neinvazivní použití in vivo
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
ATE216875T1 (de) 1999-01-27 2002-05-15 Idea Ag Nichtinvasive impfung durch die haut
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1347743B1 (en) 2000-12-07 2006-03-08 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
US6610322B1 (en) 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
GB0404993D0 (en) * 2004-03-05 2004-04-07 Univ Liverpool John Moores Method and apparatus for producing carrier complexes
JP5137256B2 (ja) * 2005-03-31 2013-02-06 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚効果剤の増強された送達
CN102940878A (zh) * 2006-10-06 2013-02-27 Scil技术股份有限公司 脊柱髓核植入物
JP5112673B2 (ja) * 2006-10-16 2013-01-09 株式会社コーセー セラミド含有組成物及びこれを配合する皮膚外用剤
WO2012100366A1 (en) 2011-01-25 2012-08-02 The Procter And Gamble Company Liposome and personal care composition comprising thereof
US10159646B2 (en) * 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
IT201700086879A1 (it) * 2017-07-28 2019-01-28 Univ Degli Studi Cagliari Vescicole lipidiche a doppio strato contenenti adrenalina, per uso nel trattamento delle emergenze cardiache
CN109224879B (zh) * 2018-09-17 2021-04-27 南京工业大学 一种cha分子筛膜的制备方法
CN113995852B (zh) * 2021-11-08 2024-01-30 河北大学 Arg-脂质体微囊、微囊包封的鱼精蛋白-siRNA复合体及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116528A (es) * 1966-09-30
US3932657A (en) * 1973-11-12 1976-01-13 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome encapsulation of chelating agents
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5323872A (en) * 1976-08-17 1978-03-04 Takeda Chem Ind Ltd Preparation of microcapsule
DE2656333C2 (de) * 1976-12-13 1985-08-08 Karl Prof. Dr.med. 7302 Ostfildern Theurer Verfahren zur Herstellung von Liposomen, welche Arzneistoffe enthalten
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
US4174296A (en) * 1978-12-04 1979-11-13 American Lecithin Company Water soluble lecithin composition
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS574913A (en) * 1980-06-11 1982-01-11 Green Cross Corp:The Urokinase preparation for oral administration
JPS5746921A (en) * 1980-09-02 1982-03-17 Green Cross Corp:The Oral preparation of human blood coagulation factor
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles
EP0102324A3 (de) * 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
FR2540381B1 (fr) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
JPS607934A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造方法
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes

Also Published As

Publication number Publication date
ATE94754T1 (de) 1993-10-15
JP2511417B2 (ja) 1996-06-26
NZ216768A (en) 1989-11-28
IL79114A (en) 1990-09-17
HUT43487A (en) 1987-11-30
ES556651A0 (es) 1987-12-16
ZA864541B (en) 1987-02-25
GR862020B (en) 1986-12-24
DE3689056D1 (de) 1993-10-28
AU5914186A (en) 1987-12-24
CN86104874A (zh) 1987-02-04
HU198836B (en) 1989-12-28
EP0211647B1 (en) 1993-09-22
NO863176L (no) 1987-02-09
IE862103L (en) 1987-02-07
PT83130A (en) 1986-09-01
FI863227A0 (fi) 1986-08-06
FI863227L (fi) 1987-02-08
DE3689056T2 (de) 1994-01-27
JPS6242733A (ja) 1987-02-24
HK1004530A1 (en) 1998-11-27
FI863227A7 (fi) 1987-02-08
KR900007185B1 (ko) 1990-09-29
EP0211647A1 (en) 1987-02-25
DK362786A (da) 1987-02-08
DK362786D0 (da) 1986-07-30
CN1027491C (zh) 1995-01-25
AU601154B2 (en) 1990-09-06
CA1280975C (en) 1991-03-05
PT83130B (pt) 1989-03-30
KR880002508A (ko) 1988-05-09
IL79114A0 (en) 1986-09-30
NO863176D0 (no) 1986-08-06
IE61445B1 (en) 1994-11-02

Similar Documents

Publication Publication Date Title
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
IL122486A (en) Process for making liposome preparation
NO171443C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syntetiske lipider
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
ES2053549T3 (es) Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
ES8801985A1 (es) Procedimiento para preparar una composicion de uso cosmetico o dermofarmaceutico en forma de una dispersion de esferulas o liposomas
DE68917603D1 (de) Verabreichung von arzneimitteln über die lungen.
EP0280492A3 (en) Liposome composition and its production
FI893504A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen, mikro- ja/tai nanopartikkeleita sisältävän yhtenäisen, kiinteän ja huokoisen muodon valmistamiseksi
ATE56358T1 (de) Chlorfluorkohlenstoff-treibstoffaerosolpr|parate, die arzneimittel enthalten.
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
PT90120B (pt) Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica
EP0458894A4 (en) LIPID EXCIPIENT FOR NASAL ADMINISTRATION AND OTHER LOCAL APPLICATIONS.
MY101791A (en) New benzimidazole derivatives
EP0728476A4 (en) LIPOSOME COMPOSITION
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
KR900701174A (ko) 인지질-함유 조성물, 이의 제조방법 및 이의 약제학적 물질용 부형제로서의 용도
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
FR2609395B1 (fr) Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee
PT81966B (pt) Processo para a preparacao de liposomas, de composicoes apropriadas para a obtensao de uma pluralidade de doses unitarias que os contem, e embalagens para a sua utilizacao
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
PT84657B (pt) Processo para a fluidificacao, mediante glicofurol, de composicoes farmaceuticas contendo fosfatidil-colina, destinadas a serem introduzidas em capsulas moles de gelatina
AU4150489A (en) Micronised drug formulation
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.